To check Oneindia News on your Mobile
go to:   http://m.oneindia.in/news/
  •  

Cerebra on acquisition mode in KPO sector

Mumbai, Feb 21 (UNI) Infused with fresh equity from vendor creditors and strategic investors, Cerebra Integrated Technologies is aiming for a concrete growth trajectory, both organic and inorganic to gross a Rs 100 crore turnover next fiscal.

The company which increased its share capital to Rs 9.2 crore with a single investor taking a 14.5 per cent stake, has emerged a debt free company having liquidated its loans from the SBI and Canara Bank on one-time settlement basis.

Its creditors were issued shares/warrants at Rs 21 per share.

Cerebra Integrated in a statement said, it was evaluating a few companies for acquisitions in the Knowledge Process Outsourcing (KPO) sector and was in the process of shortling such firms in the design and detailing services and legal process outsourcing. It aimed to buy small and mid-sized firms in India and the US for its inorganic growth.

The company also has plans to start a 50-seat architectural outsourcing business, besides a 150-seater unit for BPO, mainly concentrating on healthcare and is also looking at acquisitions in this area.

The company's Electronic Manufacturing Services division is also very aggressively putting its efforts in marketing to capture a reasonable share of the EMS market. The company also has plans for overseas acquisition in RFID area in addition to organic growth in India, the statement added.

It said the company was fully geared up to handle design, development, prototype and final box build of products to meet the customers requirements in the field of telecom, computers, wireless and related products. The company's services ranges from design engineering, assembly of printed circuit boards, assembly of electro-mechanical sub-systems and complete systems to manufacturers of telecom equipment, computers, consumer electronics, industrial electronics, automotive electronics and also medical instrumentation.

The firm plans to start an R&D centre mainly for hardware and firmware design and manufacturing services for clients in the UK and the US.

UNI VK DB SR DS1132

Gene therapy proves beneficial for patients with rheumatoid arthritis

Washington, Jan 27 (ANI): German scientists have found evidence that gene therapy reduces symptoms in patients with rheumatoid arthritis.The study led by an investigator at Beth Israel Deaconess Medical Center (BIDMC) was conducted on two patients with severe rheumatoid arthritis.Originally conceived as a means of treating genetic diseases, such as cystic fibrosis and hemophilia, gene therapy involves implanting a normal gene to compensate for a defective gene in the patient."This study helps extend gene therapy research.....
User Comments
[ Post Comments ]
Be the first to comment on this article.
Oneindia  Oneindia Login